Properties of recombinant interleukin 2‐cultured tumor‐infiltrating lymphocytes in human lung cancer

It is thought that TIL can be activated in vitro by rIL‐2 and acquire specific anti‐tumor activity. In this study, we investigated this possibility, using lymphocytes isolated from primary lung cancer tissues. In a first series of experiments, TILs and autologous PBLs from 16 patients were cultured in rIL‐2 from 7 to 14 days under identical conditions, and were compared for proliferation (16 cases), cytolytic activity (11 cases), gamma interferon (IFN‐γ) production (8 cases), and phenotypes (10 cases). TILs grew in response to rIL‐2 as well as PBLs. However, the induced cytolytic activity of TIL was significantly lower than that of PBL against autologous tumor cells and 2 human tumor cell lines. IL‐2‐mediated IFN‐γ production by TILs was also significantly lower than that of PBLs. TILs were phenotypically characterized by their high CD4/CD8 ratio and lack of Leu 11‐positive cells. Further investigations with 7 other cases showed that exogenous addition of IFN‐γ to rIL‐2 cultures of TILs enhanced cytolytic activity in 4 cases. Our results indicate that IL‐2 alone is sufficient for TILs to proliferate but not to acquire new functions (cytotoxicity and production of IFN‐γ).

[1]  J. Johnson,et al.  Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck. , 1987, Cancer research.

[2]  K. Sugimachi,et al.  Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. , 1987, Cancer research.

[3]  W. M. Linehan,et al.  A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. , 1987, The New England journal of medicine.

[4]  S. Rosenberg,et al.  Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. , 1987, Journal of immunology.

[5]  S. Rosenberg,et al.  A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. , 1986, Science.

[6]  C. Balch,et al.  Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. , 1986, Cancer research.

[7]  T. Sayers,et al.  Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation. , 1986, Journal of immunology.

[8]  S. Miescher,et al.  Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. , 1986, Journal of immunology.

[9]  K. Kawahara,et al.  Purification and characterization of recombinant human interleukin-2 produced in Escherichia coli. , 1985, Biochemical and biophysical research communications.

[10]  R. Suzuki,et al.  Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma). , 1985, Journal of immunology.

[11]  G. Trinchieri,et al.  Response of resting human peripheral blood natural killer cells to interleukin 2 , 1984, The Journal of experimental medicine.

[12]  H. Shepard,et al.  Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2. , 1984, Journal of immunology.

[13]  R. Hopkins,et al.  Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. , 1984, Journal of immunology.

[14]  J. Vilček,et al.  Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[15]  I. Kawase,et al.  Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells. , 1983, Journal of immunology.

[16]  T. Kasahara,et al.  Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets. , 1983, Journal of immunology.

[17]  S. Rosenberg,et al.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.

[18]  W. Farrar,et al.  Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. , 1981, Journal of immunology.

[19]  T. Tötterman,et al.  Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. III. Further functional investigations using cultured autochthonous tumor cell lines and freeze-thawed infiltrating inflammatory cells. , 1980, Cellular immunology.

[20]  M. Moore,et al.  Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours , 1979, International journal of cancer.

[21]  A. Belldegrun,et al.  Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. , 1988, Cancer research.

[22]  E. Holmes,et al.  Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors. , 1985, Cancer research.